Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Polycystic ovary syndrome
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Associated conditions === Warning signs may include a change in appearance. But there are also manifestations of mental health problems, such as anxiety, depression, and eating disorders.<ref name="vice.com" />{{Medical citation needed|date=July 2022}} A diagnosis of PCOS suggests an increased risk of the following: * [[Endometrial hyperplasia]] and [[endometrial cancer]] (cancer of the uterine lining) are possible, due to overaccumulation of the uterine lining, and also lack of [[progesterone]], resulting in prolonged stimulation of uterine cells by estrogen.<ref name="emedicine_main" /><ref name="BarryAzizia2014" /> It is not clear whether this risk is directly due to the syndrome or from the associated obesity, [[hyperinsulinemia]], and [[hyperandrogenism]].<ref>{{cite journal |vauthors=New MI |title=Nonclassical congenital adrenal hyperplasia and the polycystic ovarian syndrome |journal=Annals of the New York Academy of Sciences |volume=687 |issue=1 |pages=193β205 |date=May 1993 |pmid=8323173 |doi=10.1111/j.1749-6632.1993.tb43866.x |s2cid=30161989 |bibcode=1993NYASA.687..193N }}</ref><ref name="pmid12781553">{{cite journal | vauthors = Hardiman P, Pillay OC, Atiomo W | title = Polycystic ovary syndrome and endometrial carcinoma | journal = Lancet | volume = 361 | issue = 9371 | pages = 1810β2 | date = May 2003 | pmid = 12781553 | doi = 10.1016/S0140-6736(03)13409-5 | s2cid = 27453081 }}</ref><ref>{{cite journal | vauthors = Mather KJ, Kwan F, Corenblum B | title = Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity | journal = Fertility and Sterility | volume = 73 | issue = 1 | pages = 150β6 | date = January 2000 | pmid = 10632431 | doi = 10.1016/S0015-0282(99)00468-9 | doi-access = free }}</ref> * [[Insulin resistance]]/[[type 2 diabetes]]. A review published in 2010 concluded that women with PCOS have an elevated prevalence of insulin resistance and type 2 diabetes, even when controlling for [[body mass index]] (BMI).<ref name=emedicine_main /><ref>{{cite journal | vauthors = Moran LJ, Misso ML, Wild RA, Norman RJ | title = Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis | journal = Human Reproduction Update | volume = 16 | issue = 4 | pages = 347β363 |date= 2010 | pmid = 20159883 | doi = 10.1093/humupd/dmq001 | doi-access = free }}</ref> PCOS is also associated with higher risk for diabetes.<ref>{{cite book |vauthors=Falcone T, Hurd RW |title=Clinical Reproductive Medicine and Surgery |date=2007 |publisher=Elsevier Health Sciences |isbn=978-0-323-03309-1 |page=223 |url=https://books.google.com/books?id=fOPtaEIKvcIC&pg=PA223 |language=en |access-date=24 May 2020 |archive-date=14 January 2023 |archive-url=https://web.archive.org/web/20230114012631/https://books.google.com/books?id=fOPtaEIKvcIC&pg=PA223 |url-status=live }}</ref> * [[High blood pressure]], in particular if obese or during pregnancy<ref>{{cite web |title=Polycystic ovary syndrome (PCOS) - Symptoms and causes |url=https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439 |website=Mayo Clinic |access-date=26 June 2021 |archive-date=21 November 2021 |archive-url=https://web.archive.org/web/20211121111442/https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439 |url-status=live }}</ref> * [[Depression (mood)|Depression]] and [[anxiety (mood)|anxiety]]<ref name=BMC2010 /><ref>{{cite journal | vauthors = Barry JA, Kuczmierczyk AR, Hardiman PJ | title = Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis | journal = Human Reproduction | volume = 26 | issue = 9 | pages = 2442β51 | date = September 2011 | pmid = 21725075 | doi = 10.1093/humrep/der197 | doi-access = free }}</ref> * [[Dyslipidemia]] β disorders of lipid metabolism β cholesterol and triglycerides. Women with PCOS show a decreased removal of [[atherosclerosis]]-inducing remnants, seemingly independent of insulin resistance/type 2 diabetes.<ref>{{cite journal | vauthors = Ovalle F, Azziz R | title = Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus | journal = Fertility and Sterility | volume = 77 | issue = 6 | pages = 1095β1105 | date = June 2002 | pmid = 12057712 | doi = 10.1016/s0015-0282(02)03111-4 | doi-access = free }}</ref> * [[Cardiovascular disease]],<ref name=emedicine_main /> with a meta-analysis estimating a 2-fold risk of arterial disease for women with PCOS relative to women without PCOS, independent of BMI.<ref>{{cite journal | vauthors = de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM | title = PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis | journal = Human Reproduction Update | volume = 17 | issue = 4 | pages = 495β500 | date = 1 July 2011 | pmid = 21335359 | doi = 10.1093/humupd/dmr001 | doi-access = free }}</ref> * [[Stroke]]s<ref name=emedicine_main /> * [[Weight gain]]{{citation needed|date=May 2024}} * [[Miscarriage]]<ref name="pmid18277353">{{cite journal | vauthors = Goldenberg N, Glueck C | title = Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation | journal = Minerva Ginecologica | volume = 60 | issue = 1 | pages = 63β75 | date = February 2008 | pmid = 18277353 | url = https://www.minervamedica.it/en/journals/minerva-obstetrics-gynecology/article.php?cod=R09Y2008N01A0063 | access-date = 13 October 2021 | archive-date = 2 November 2021 | archive-url = https://web.archive.org/web/20211102082813/https://www.minervamedica.it/en/journals/minerva-obstetrics-gynecology/article.php?cod=R09Y2008N01A0063 | url-status = live }}</ref><ref name="pmid18181085">{{cite journal | vauthors = Boomsma CM, Fauser BC, Macklon NS | title = Pregnancy complications in women with polycystic ovary syndrome | journal = Seminars in Reproductive Medicine | volume = 26 | issue = 1 | pages = 72β84 | date = January 2008 | pmid = 18181085 | doi = 10.1055/s-2007-992927 | s2cid = 260316768 }}</ref> * [[Sleep apnea]], particularly if obesity is present{{citation needed|date=May 2024}} * [[Non-alcoholic fatty liver disease]], particularly if obesity is present{{citation needed|date=May 2024}} * [[Acanthosis nigricans]] (patches of darkened skin under the arms, in the groin area, on the back of the neck)<ref name=emedicine_main /> * [[Autoimmune thyroiditis]]{{citation needed|date=June 2018}} * [[Iron deficiency]]<ref>{{Cite web |title=Iron Deficiency Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025 |url=https://www.imarcgroup.com/iron-deficiency-injectables-market |access-date=2 August 2023 |website=imarc |archive-date=2 August 2023 |archive-url=https://web.archive.org/web/20230802112545/https://www.imarcgroup.com/iron-deficiency-injectables-market |url-status=live }}</ref>{{better source needed|date=September 2024}} The risk of [[ovarian cancer]] and [[breast cancer]] is not significantly increased overall, but women with PCOS were about three times more likely to develop [[endometrial cancer]] than other women.<ref name="BarryAzizia2014">{{cite journal | vauthors = Barry JA, Azizia MM, Hardiman PJ | title = Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis | journal = Human Reproduction Update | volume = 20 | issue = 5 | pages = 748β758 | date = 1 September 2014 | pmid = 24688118 | pmc = 4326303 | doi = 10.1093/humupd/dmu012 }}</ref> Some medical providers and groups consider PCOS to be an [[intersex]] condition because some sex hormones are outside the typical range.<ref>Tara Becker, Marshall Chin, and Nancy Bates (9 Mar 2022). [http://www.ncbi.nlm.nih.gov/books/NBK581039/ "Measuring Sex, Gender Identity, and Sexual Orientation".] ''National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Committee on National Statistics; Committee on Measuring Sex, Gender Identity, and Sexual Orientation''. Washington DC: National Academies Press (US). 7, Measuring Intersex/DSD Populations. [https://web.archive.org/web/20250201221206/https://www.ncbi.nlm.nih.gov/books/NBK581039/ Archived] from the original on 1 February 2025. Retrieved 12 February 2025.</ref> However, medical consensus, including the Endocrine Society and NIH, defines PCOS as an endocrine/metabolic disorder, not intersex, as it lacks congenital sex characteristic variations.<ref>{{Cite journal |last1=Singh |first1=Samradhi |last2=Pal |first2=Namrata |last3=Shubham |first3=Swasti |last4=Sarma |first4=Devojit Kumar |last5=Verma |first5=Vinod |last6=Marotta |first6=Francesco |last7=Kumar |first7=Manoj |date=11 February 2023 |title=Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics |journal=Journal of Clinical Medicine |language=en |volume=12 |issue=4 |pages=1454 |doi=10.3390/jcm12041454 |doi-access=free |pmid=36835989 |pmc=9964744 |issn=2077-0383 }}</ref><ref>{{Cite web |date=24 January 2022 |title=Polycystic Ovary Syndrome |url=https://www.endocrine.org/patient-engagement/endocrine-library/pcos |access-date=7 March 2025 |website=www.endocrine.org |language=en}}</ref> A 2023 study notes two transmasculine individuals self-identified as intersex without medical diagnosis, tying it to identity, not biology.<ref>{{Cite journal |last1=Wugalter |first1=Katrina |last2=Perovic |first2=Mateja |last3=Karkaby |first3=Laurice |last4=Einstein |first4=Gillian |date=2 April 2024 |title=The double-edged sword of PCOS and gender: exploring gender-diverse experiences of polycystic ovary syndrome |journal=International Journal of Transgender Health |language=en |volume=25 |issue=2 |pages=251β267 |doi=10.1080/26895269.2023.2183448 |pmid=38681493 |pmc=11044764 |issn=2689-5269}}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Polycystic ovary syndrome
(section)
Add topic